Advances in the Management of Liver Cancer, Webinar Recording

A Multidisciplinary Approach: Second Annual

Complimentary Program: Virtual

Program Overview

This webinar was recorded on Wednesday, June 28, 2023.

Join us at the 2nd Annual “Advances in the Management of Liver Cancer: A Multidisciplinary Approach” CME event. This free full-day course focuses on epidemiology, screening, and biomarkers for hepatocellular carcinoma (HCC), evolving therapeutic approaches to HCC, including surgical, locoregional, systemic, and combination therapies, and updates on the diagnosis and treatment of cholangiocarcinoma (CCA). The format will include expert didactic lectures, case presentations, and panel discussions with interactive audience Q&A.

Learning Objectives

Understand the recent changes in epidemiology of HCC and adjustments in screening and surveillance guidelines
Explain the most up-to-date medical oncology management of HCC including recent advances in immunotherapy
Understand current therapeutic options for treatment of CCA
Understand the multidisciplinary approach needed for liver cancers (HCC and CCA) including hepatology, medical oncology, interventional radiology, and surgical expertise

Target Audience

This activity is designed for oncology providers, including surgeons, physicians, fellows, residents, nurse practitioners, and physician assistants who manage patients with hepatocellular carcinoma (HCC) across various clinical specialties including; general & transplant surgery, oncology, immunology, pulmonology, cardiology, gastroenterology, infectious disease, neuroscience & radiology. While this educational content is geared towards health care professionals, we believe this topic will appeal to an even wider audience.

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Columbia University Department of Surgery and Amedco LLC. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement

PHYSICIANS

Amedco LLC designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PHYSICIAN ASSISTANTS

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 5.25 AMA PRA Category 1 Credits™ for completing this activity.

NURSE PRACTITIONERS

The American Academy of Nurse Practitioners Certification Board (AANPCB) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit.

Satisfactory Completion

Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed above, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Method of Participation

You will receive a confirmation email before the event with instructions for joining via Zoom.

Registration Fees

Registration Options

All Healthcare Professionals: Free

Agenda

Wednesday, June 28

10:30 AM - 10:35 AM

Welcoming Remarks

Tomoaki Kato, MD & Elizabeth C. Verna, MD, MS Columbia University Irving Medical Center

10:35 AM

SESSION I: Update in HCC Epidemiology, Biomarkers and Screening

Moderators: Meaghan Phipps, MD, Elizabeth C. Verna, MD, MS

10:35 AM - 10:55 AM

Evolving Epidemiology of HCC and Disparities in HCC Outcomes

Meaghan Phipps, MD NYP/Columbia University Irving Medical Center

10:55 AM - 11:15 AM

Novel Insights into the Pathogenesis of HCC

Utpal Pajvani, MD, PhD Herbert Irving Associate Professor of Medicine Columbia University Irving Medical Center

11:15 AM - 11:35 AM

Update on Screening & Novel Biomarkers for HCC

Amit Singal, MD Professor and Chief of Hepatology University of Texas Southwestern

11:35 AM - 11:55 AM

Diagnostic Approach to Solid Liver Lesions and LIRADS Criteria

Benjamin Navot, MD Assistant Professor of Radiology at CUMC MRI Medical Director Columbia University Irving Medical Center

11:55 AM - 12:10 PM

Panel Discussion | Q&A Session

12:10 PM - 12:20 PM

Break | Virtual Exhibit Hall

12:20 PM

SESSION II: Multi-Disciplinary and Multi-Modality Treatment for HCC

Moderators: Elizabeth C. Verna, MD, MS, Tomoaki Kato, MD

12:20 PM - 1:00 PM

KEYNOTE: Immunotherapy for HCC: Current Recommendations and Future Directions

Mark Yarchoan, MD Associate Professor of Oncology Johns Hopkins University

1:00 PM - 1:20 PM

Interventional Radiology Approaches to HCC Treatments: TACE, Y90 and Ablation

Joshua Weintraub, MD Professor of Radiology Executive Vice Chairman of the Department of Radiology Chief of the Division of Vascular and Interventional Radiology Columbia University Irving Medical Center

1:20 PM - 1:50 PM

Transplant for HCC: Criteria & Outcomes

Abhishek Mathur, MD Assistant Professor of Surgery Columbia University Irving Medical Center

1:45 PM - 2:15 PM

Moderated Case Presentation with Panel Discussion (40 min.) Treatment of HCC; Systemic Therapy, IR-Based Treatment and Liver Transplantation

Alyson Fox, MD, MS Associate Professor of Medicine Medical Director of Liver Transplantation Columbia University Irving Medical Center Panel: Elizabeth Verna,MD Tomoaki Kato,MD Mark Yaorchon, MD Joshua Weintraub, MD Abhishek Mathur, MD

2:30 PM - 2:40 PM

Break

2:40 PM

SESSION III: Update on the Diagnosis and Management of CCA

Moderators: Jean Emond, MD, Ruth White, MD, PhD

2:40 PM - 3:00 PM

Epidemiology and Pathogenesis of CCA

Ruth White, MD, PhD Instructor in Medicine at the Columbia University Medical Center

3:00 PM - 3:20 PM

Surgical Approaches to CCA Treatment

Jean Emond, MD Professor of Surgery Vice Chair, Department of Surgery Chief of Transplantation Services, Columbia University Columbia University Irving Medical Center

3:20 PM - 3:50 PM

Role of System and Combination Therapies in CCA Management

Susan E. Bates, MD Columbia University Irving Medical Center

3:50 PM - 4:10 PM

Q&A Session | Panel Discussion

4:10 PM - 4:15 PM

Closing Remarks

Tomoaki Kato, MD and Elizabeth Verna, MD NYP/Columbia University Irving Medical Center, New York, NY, USA

Faculty